- Home
- KYMR vs FORM Comparison
KYMR vs FORM Comparison
Compare KYMR & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- FORM
- Stock Information
- Founded
- KYMR 2015
- FORM 1993
- Country
- KYMR United States
- FORM United States
- Employees
- KYMR N/A
- FORM N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- FORM Semiconductors
- Sector
- KYMR Health Care
- FORM Technology
- Exchange
- KYMR Nasdaq
- FORM Nasdaq
- Market Cap
- KYMR 2.1B
- FORM 2.9B
- IPO Year
- KYMR 2020
- FORM N/A
- Fundamental
- Price
- KYMR $33.45
- FORM $30.58
- Analyst Decision
- KYMR Buy
- FORM Buy
- Analyst Count
- KYMR 13
- FORM 8
- Target Price
- KYMR $56.69
- FORM $48.00
- AVG Volume (30 Days)
- KYMR 695.8K
- FORM 820.2K
- Earning Date
- KYMR 05-01-2025
- FORM 04-30-2025
- Dividend Yield
- KYMR N/A
- FORM N/A
- EPS Growth
- KYMR N/A
- FORM N/A
- EPS
- KYMR N/A
- FORM 0.89
- Revenue
- KYMR $47,072,000.00
- FORM $763,599,000.00
- Revenue This Year
- KYMR $44.93
- FORM $4.29
- Revenue Next Year
- KYMR N/A
- FORM $7.08
- P/E Ratio
- KYMR N/A
- FORM $34.37
- Revenue Growth
- KYMR N/A
- FORM 15.16
- 52 Week Low
- KYMR $29.07
- FORM $30.22
- 52 Week High
- KYMR $53.27
- FORM $63.63
- Technical
- Relative Strength Index (RSI)
- KYMR 44.68
- FORM 30.84
- Support Level
- KYMR $31.54
- FORM $30.22
- Resistance Level
- KYMR $31.66
- FORM $33.47
- Average True Range (ATR)
- KYMR 2.31
- FORM 1.51
- MACD
- KYMR 0.37
- FORM -0.05
- Stochastic Oscillator
- KYMR 51.20
- FORM 6.30
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.